Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?

Audrey Benyamine (1) , Daniel Bertin (2) , Xavier Heim (1) , Brigitte Granel (3, 1) , Nathalie Bardin (1)

1 VRCM - Vascular research center of Marseille
2 Laboratoire d'immunologie, Pôle de Biologie
3 Hôpital Nord [CHU - APHM]

Mots clés: Immunofluorescence pattern; Anti-topoisomerase I antibodies; Anti-centromere antibodies; Anti-RNA polymerase III antibodies; Systemic sclerosis

Domaines: Immunologie

Audrey Benyamine, Daniel Bertin, Xavier Heim, Brigitte Granel, Nathalie Bardin. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?. European Journal of Internal Medicine, 2017, 44, pp.e42-e44. ⟨10.1016/j.ejim.2017.07.033⟩. ⟨hal-01792225⟩